Biolase, Inc. (BIOL) stock prices updated...

Biolase, Inc. stock price

Biolase, Inc. latest news:

  • 09/29/2017 06:12:22

    BRIEF-BIOLASE ‍expects about $8 mln to $12 mln for rights offering to stockholders

    BIOLASE Inc(BIOL). * BIOLASE(BIOL) announces plans for rights offering to stockholders. * BIOLASE Inc (BIOL) says ‍expects to receive gross proceeds of approximately $8 million to $12 million before expenses​ Source text for Eikon: Further company coverage:

  • More trends:

    BioLife Solutions, Inc.BLFS | BioLineRx Ltd.BLRX | BioMarin Pharmaceutical Inc.BMRN | BiondVax Pharmaceuticals Ltd.BVXV | BiondVax Pharmaceuticals Ltd.BVXVW | Bio-Path Holdings, Inc.BPTH | BioScrip, Inc.BIOS | BioShares Biotechnology Clinical Trials FundBBC | BioShares Biotechnology Products FundBBP | BioSpecifics Technologies CorpBSTC |